+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Polyneuropathy Drug"

From
From
From
From
From
Familial Amyloid Neuropathies - Pipeline Review, H1 2020 - Product Thumbnail Image

Familial Amyloid Neuropathies - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 98 Pages
  • Global
From
From
From
  • 10 Results (Page 1 of 1)
Loading Indicator

Polyneuropathy is a type of neurological disorder that affects multiple peripheral nerves, leading to numbness, weakness, and pain in the hands and feet. It is a common complication of diabetes, and can also be caused by autoimmune diseases, infections, and other conditions. Treatment for polyneuropathy typically involves medications to reduce pain and improve nerve function. Central nervous system (CNS) drugs are used to treat a variety of neurological disorders, including polyneuropathy. These drugs can be divided into two categories: analgesics, which are used to reduce pain, and neuroprotective agents, which are used to protect nerve cells from damage. Commonly prescribed CNS drugs for polyneuropathy include anticonvulsants, antidepressants, and antispasmodics. Several companies are involved in the polyneuropathy drug market, including Pfizer, GlaxoSmithKline, Merck, and Novartis. These companies produce a variety of CNS drugs for the treatment of polyneuropathy, including pregabalin, duloxetine, and gabapentin. Show Less Read more